Startup Diligence
Diligence report Healthcare software / senior care SaaS / long-term and post-acute care EHR Private growth-stage unicorn / growth-equity-backed healthcare SaaS

PointClickCare Technologies Inc. / PointClickCare Corp.

PointClickCare Startup Diligence Research Report

The attractive thesis is a scaled incumbent in senior-care/post-acute healthcare software with broad product, customer and data-network reach. The underwriting hinge is whether current ARR quality, retention, product economics, legal/regulatory posture and growth outside core LTPAC justify the private-market valuation.

Company profile

PointClickCare Startup Diligence Research Report

Proceed with diligence, not investment decision: PointClickCare passes the public stop-condition screen and appears to be a substantial private healthcare SaaS company, but current financials, cap table, contracts, customer concentration, PHI/security controls and interoperability litigation require data-room and counsel review.

Website
pointclickcare.com
Sector
Healthcare software / senior care SaaS / long-term and post-acute care EHR
Geography
Canada and United States; headquartered in Mississauga, Ontario per SEC filings
Stage
Private growth-stage unicorn / growth-equity-backed healthcare SaaS
Known aliases
PointClickCare, PointClickCare Technologies, PointClickCare Technologies Inc., PointClickCare Corp., Wescom Solutions Inc.
Report version
1.0
Timezone
America/Toronto

Executive summary

Strengths

  • Historical IPO registration was withdrawn in 2017; no public evidence of IPO completion, acquisition or shutdown was found.
  • BusinessWire release supports founder-control continuity after the 2021 H&F/Dragoneer minority investment.
  • Current company pages verify broad product/vertical coverage across senior living, skilled nursing and cross-continuum healthcare workflows.
  • Trust Center and Privacy Policy confirm regulated PHI/PII context and disclosed security/privacy posture.

Risks

  • Current audited financials, ARR, debt/cash, cap table and valuation terms are not public.
  • Real Time litigation creates material interoperability/API access and information-blocking diligence risk.
  • PHI/PII handling creates high privacy, cybersecurity and healthcare-regulatory exposure.
  • Customer concentration, churn and satisfaction are hidden behind curated stories and aggregate scale claims.
  • Secondary-heavy 2021 transaction evidence means headline valuation may not equal current primary enterprise value.

Gaps

  • Audited financial statements, ARR/NRR/churn cohorts, cash/debt, gross margin and management projections.
  • Capitalization table, liquidation preferences, investor rights, secondary/tender documents and employee equity plan.
  • Top-customer ARR/concentration, renewal calendar, customer references and churn/downsells.
  • SOC/HITRUST reports, HIPAA/PHIPA risk assessments, breach logs, cyber insurance and regulatory searches.
  • Real Time litigation current status, API/interoperability policy and information-blocking legal analysis.

Recommended next steps

  • Open a financial/legal/security data room and prioritize gaps G-001 through G-006 and G-013 through G-016.
  • Have healthcare regulatory and litigation counsel review Real Time, information-blocking exposure, BAAs/DPAs and agency/breach searches.
  • Run CFO/CEO/CPO/CISO diligence calls plus at least six permissioned customer/reference calls across SNF, senior living, hospital and risk-bearing segments.
  • Reconcile US$4B screening valuation with current valuation materials, secondary sale terms and later public US$5B+ reports.
  • Perform product demos and technical review focused on AI Resident Status, marketplace/API governance, uptime and security controls.

Risk register

high high likelihood

R-001: Current financial statements and valuation terms are not public

Public sources support large scale and a historic unicorn valuation, but current audited financials, ARR, EBITDA, cash/debt, revenue quality and valuation preferences are unavailable.

Diligence request: Request audited financials, monthly ARR bridge, cohort retention, cash/debt schedule, budget/plan and valuation/cap-table materials.

high medium likelihood

R-002: Information-blocking/API access litigation risk

Real Time Medical Systems litigation shows that third-party access to PointClickCare EHR data can become a material legal/regulatory and customer-relations issue.

Diligence request: Counsel should review current docket status, settlement posture, information-blocking analysis, API policies and customer notices.

high medium likelihood

R-003: PHI/privacy/cybersecurity exposure

The platform handles PHI/PII and serves regulated healthcare workflows; disclosed SOC/HITRUST claims must be validated against reports, exceptions and incident history.

Diligence request: Obtain SOC/HITRUST reports, HIPAA/PHIPA assessments, breach logs, cyber-insurance policies, subprocessor list and security incident metrics.

high medium likelihood

R-011: Healthcare regulatory change and contract compliance burden

HIPAA/PHIPA/privacy, ONC/Cures Act information blocking, CMS/state reporting and customer BAAs/SLAs can materially affect product design and liability.

Diligence request: Have healthcare regulatory counsel review compliance roadmap, material contracts, BAAs, customer notices and regulatory correspondence.

medium high likelihood

R-004: Customer concentration, churn and satisfaction unknown

Public scale claims and curated customer stories do not disclose top-customer ARR, churn, NRR, contract terms or satisfaction metrics.

Diligence request: Request customer concentration table, renewal/churn cohorts, NPS/CSAT, aging/AR and permissioned reference calls.

medium high likelihood

R-007: Secondary transaction and cap-table opacity

Independent press indicates a 2021 secondary-heavy transaction, but investor rights, preferences, liquidity waterfalls and employee-tender effects are not public.

Diligence request: Obtain capitalization table, preferred-stock terms, voting agreements, ROFR/co-sale, tender documents and option-pool history.

medium medium likelihood

R-005: Competitive and pricing pressure in post-acute/cross-continuum software

MatrixCare, Netsmart and WellSky publicly market overlapping solutions, while acute/payer expansion exposes PointClickCare to larger EHR/data-network incumbents.

Diligence request: Request win/loss, competitive displacement data, discounting by competitor and product roadmap differentiation.

medium medium likelihood

R-006: Partner ecosystem and integration dependency risk

Marketplace and acquisition-driven expansion can depend on partners, APIs, integration reliability and data-rights governance.

Diligence request: Review partner contracts, integration uptime, partner security reviews, API SLAs and acquisition integration KPIs.

Chapter 01

01Financial Information

Public evidence supports PointClickCare as a mature private healthcare SaaS company and validates a 2021 US$4B unicorn screen, but current audited financials, ARR, profitability, debt, cash and valuation preferences are not public.

I.A Annual and quarterly financial information for the past three years

not publicly verifiable confidence: medium

Current annual/quarterly financial statements were not public. Historical SEC filings and later press estimates indicate substantial scale, but data-room financials are required.

Evidence gaps

  • Audited statements, monthly management accounts, ARR bridge, deferred revenue, gross margin, EBITDA, cash/debt and KPI cohorts are missing.

Hidden risks

  • Current ARR, EBITDA, cash/debt and revenue quality could materially diverge from public estimates.

Follow-up questions

  • Provide audited financial statements for the last three fiscal years and monthly financials for the trailing 24 months.
  • Provide ARR/NRR/churn by product and segment.
Public financial and operating scale signals
MetricPeriodValueSource qualityDiligence use
Revenue2015 fiscal yearUS$125.4MHigh - SEC F-1/A historicalBaseline for long-term growth but not current underwriting
RevenueLater public estimateAbove US$500M; roughly 20% growthMedium - Communitech articleSuggests large profitable scale; request audited financials
Customer/facility footprint2016 SEC filingAbout 2,400 providers; 12,200 facilities; 925,000 residents/dayHigh - SEC historicalHistorical penetration benchmark
Provider/hospital footprint2021-2022 public reports21,000+ LTPAC providers / about 65% of U.S. SNFs; later 27,000+ LTC providers and 2,700 hospitalsMedium - company release/independent articleScale claim; verify definitions and active paying customers
Profitability/cash/debtCurrentNot publicly disclosedLow - no data-room financialsCritical diligence gap before investment decision

Mixes historical filings and public article estimates; not a substitute for financial statements.

Public valuation and scale signals Bar chart of selected public financial/scale data points with mixed units noted.

Mixed units are intentional; render with labels rather than comparing bars directly.

I.B Financial Projections

not publicly verifiable confidence: low

No current management projections or budget variance data were public. Public scale supports diligence interest but not forecast underwriting.

Evidence gaps

  • Board-approved plan, forecast model, assumptions, bookings pipeline, hiring plan and variance history are missing.

Hidden risks

  • Growth-equity investors may underwrite aggressive expansion into acute/payer segments without public evidence of CAC/payback or roadmap delivery.

Follow-up questions

  • Provide board-approved financial plan and actual-vs-plan performance for the last eight quarters.
  • Provide sensitivity cases for retention, bookings, gross margin and R&D investment.
Sales productivity and budget diligence gaps
Metric or inputPublic statusWhy criticalRequested source
CAC and paybackNot publicDetermines scalability of direct enterprise GTMFinance/S&M dashboards
Pipeline conversion by verticalNot publicValidates expansion into hospitals/risk-bearing providersCRM exports and board decks
Quota attainment and rep rampNot publicMeasures sales-force productivity and hiring needsSales ops reports
Marketing budget sufficiencyNot publicLarge enterprise segments may require different demand-gen motionsBudget and campaign ROI reports
Partner-sourced pipelineNot publicMarketplace channel economics may be materialPartner ops and marketplace analytics

All metrics should be requested for the past eight quarters where possible.

I.C Capital Structure

partially verified confidence: medium

Public evidence identifies founders, H&F, Dragoneer and JMI-related secondary activity, but exact capitalization, investor rights and preferences are not public.

Evidence gaps

  • Current cap table, option pool, voting rights, liquidation preferences, debt and secondary documents are missing.

Hidden risks

  • Secondary-heavy deals can create misread valuation signals and undisclosed investor preferences.

Follow-up questions

  • Provide fully diluted capitalization table and all equity/debt financing documents.
  • Provide 2021 secondary-sale/tender documents and current investor-rights agreements.
Public ownership and capitalization signals
Holder or groupPublic signalUnknownsRisk link
Mike and David Wessinger/foundersBusinessWire stated founders would continue to control and operate after 2021 transactionVoting %, board rights, employment agreements, succession, founder liquidityGovernance/key-person and control risk
Hellman & FriedmanNew minority strategic investor with board seat in 2021 releasePreferred terms, vetoes, information rights, transfer rightsFinancing/governance terms unknown
Dragoneer Investment GroupExisting investor increased investment in 2021; press references prior 2017/2018 investmentsSeries/secondary purchase terms and current ownershipCap-table opacity
JMI Equity and other sellersCompany thanked JMI; independent press reported JMI mostly cashed out / stock sale by existing holdersRemaining ownership, reps/indemnities, sale proceeds allocationSecondary transaction terms may affect current valuation interpretation
Employees/option holdersBetaKit reported employees among sellers in secondary saleOption pool, retention grants, exercise windows, tender detailsTalent retention and dilution unknown

No public capitalization table or waterfall was available.

Public funding and liquidity event chronology
DateEventReported amount or termsEvidence strengthDiligence implication
2015-09 to 2016-06F-1/F-1A registration processHigh - SEC filingHistorical public-market attempt, but stale financials only
2017-02-01Form RW withdrawalHigh - SEC filingNo stop condition from historical IPO filing
2017-2018Growth/secondary rounds referenced by CB Insights/BetaKitMedium - market database/pressNeed securities ledgers to distinguish primary from secondary proceeds
2021-01-06H&F minority strategic investment; Dragoneer increased investmentMedium/high - company release + independent pressCore unicorn valuation evidence; cap table and preferences unknown
2024-02-20CB Insights latest funding entryMedium - market databaseNot material to valuation but confirms database activity

Amounts from private-company databases/press should be reconciled against ledgers and closing sets.

Public financing and IPO-status timeline Timeline of public filings and financing/secondary evidence relevant to eligibility.

I.D Other financial information

partially verified confidence: medium

SEC filings establish that the historical IPO registration was withdrawn. No public stop-event evidence was found, but private-company financial controls and tax matters remain unknown.

Evidence gaps

  • Tax audits, debt/covenants, off-balance-sheet obligations and revenue-recognition policies are missing.

Hidden risks

  • Private M&A/recapitalization or material debt could be non-public.

Follow-up questions

  • Provide tax returns, debt schedules, lease/commitment schedules and revenue recognition memos.
  • Reconfirm no IPO/acquisition/shutdown event before committee.
Chapter 02

02Products

PointClickCare publicly markets a broad healthcare software portfolio for senior living, skilled nursing, providers, hospitals, risk-bearing organizations and ecosystem partners. The main diligence gap is not product existence but adoption, pricing, module economics, AI validation and roadmap execution.

II.A Description of each product

partially verified confidence: medium

Public product pages identify a multi-product platform including senior living EHR, skilled nursing workflows, billing, care/service delivery, integrations, marketplace, cross-continuum solutions and AI-enabled nursing support. Pricing, attach rate and product-level financials are not public.

Evidence gaps

  • SKU-level ARR, retention, attach rates, pricing, roadmap dates, model validation and customer support metrics are missing.

Hidden risks

  • Product breadth may mask uneven adoption, support burden or margin differences by module.
  • AI claims could create clinical, reputational or regulatory risk without validation.

Follow-up questions

  • Provide product revenue by SKU, attach-rate cohorts and gross margin by product family.
  • Provide AI/model governance, validation, incident handling and product roadmap materials.
Product and vertical coverage matrix
Product or solutionTarget usersCapabilitiesEvidence statusDiligence questions
Senior Living EHR / senior-living platformSenior living operators and staffEHR, wellness coordination, resident engagement, reporting dashboards, secure communication/mobile collaborationCompany-verified marketing claimAttach rate, module usage, migration complexity, gross margin
Skilled nursing / core senior-care EHRSkilled nursing facilities and LTPAC providersEHR/RCM/care workflows inferred from historical filings and current vertical pagesCompany/SEC-supportedCurrent SNF share, churn, regulatory update cost
Billing, care/service delivery, lab and imaging packagesProviders using add-on modulesOperational and integration packages listed in product catalogCompany-verified product taxonomyModule-level ARR, attach rates, partner dependencies
Nursing Support Package / Resident StatusNursing teams and facility operatorsAI-powered Resident Status positioningCompany-verified; efficacy unverifiedModel validation, false positives, clinical workflow adoption
Hospitals, health systems, ACO/risk-bearing provider solutionsAcute-care organizations, payers and risk-bearing providersCross-continuum coordination and optimization use casesCompany-verified positioningRevenue mix, win/loss vs acute-care EHRs and data networks

Public product taxonomy is strong; pricing and adoption data are not public.

Pricing, packaging and unit economics gap table
AreaPublic evidenceStatusWhy it matters
Published list pricesNo public price card located; pages route to demo/contact pathsNot publicly verifiableNeeded for ACV, discounting and competitive-pressure analysis
Implementation and services feesNo public services pricing or implementation backlog metrics locatedNot publicly verifiableAffects gross margin, time-to-value and churn risk
Module attach ratesProduct catalog lists many modules but not penetration by customer cohortNot publicly verifiableCore to expansion ARR thesis
Product-level gross marginNo current product-level financials publicNot publicly verifiableAI, data exchange and support intensity may carry different margins
AI product economicsAI-powered Resident Status publicly marketed; no model operating cost or outcome metrics publicPartially verified product existence; economics missingDetermines defensibility and risk of overclaiming AI outcomes

Enterprise SaaS price opacity is normal but blocks standalone underwriting.

Public product architecture map Conceptual map of public product families and ecosystem around core senior-care EHR workflows.

Conceptual; not a company-provided architecture diagram.

Chapter 03

03Customer Information

Public sources show meaningful logo/use-case breadth and large provider scale, but top-customer concentration, revenue mix, churn, retention and supplier dependencies are not public.

III.A Top customers by application

partially verified confidence: medium

Public customer stories provide examples across payer/risk-bearing, physician practice, hospital/ED, marketplace and long-term-care use cases, but they are not top customers by revenue.

Evidence gaps

  • Top 20 customers by ARR, logo retention, segment mix and reference permissions are missing.

Hidden risks

  • Curated logos may overstate customer satisfaction or current relationship scope.

Follow-up questions

  • Provide top-customer ARR and reference-call list by segment.
  • Reconcile public customer counts to active paying logos and facilities.
Named customer-story signals
Customer or storyUse caseSegment signalEvidence caveat
Tandigm HealthPAC Management IQ / risk-bearing provider use casePayer/risk-bearing providerCompany-curated story; no ARR or independent reference call
Transitional Care PhysiciansEHR for Practice GroupsPractice group/post-acute physician workflowsNo contract terms or utilization metrics
Torrance Memorial / MLKED Optimization storyHospital/health-system workflowNo revenue contribution or implementation scope
Westmoreland ManorMarketplace storyLTPAC customer using ecosystem integrationsNo partner economics or renewal history
Ascension-related contentCustomer-story hub referenceLarge health-system signalMust validate current relationship and scope

These are not represented as top customers by revenue; they are public logo/use-case evidence.

Customer footprint scale signals Bar chart of customer/provider/facility/hospital scale indicators from public sources.

Use as scale signals, not as normalized customer counts.

III.B Strategic relationships

partially verified confidence: medium

Marketplace, investor relationships and acquisition history are visible public signals, but partner economics and integration performance are not public.

Evidence gaps

  • Partner roster, revenue share, partner-sourced ARR, API terms and acquisition integration KPIs are missing.

Hidden risks

  • Partner/API disputes and integration delays can affect customer value and legal exposure.

Follow-up questions

  • Provide partner marketplace economics and top partner contracts.
  • Provide integration roadmap and KPIs for acquired assets.
Strategic relationships and ecosystem signals
RelationshipPublic signalPotential valueDiligence need
Marketplace partner ecosystemCompany marketplace page positions partner ecosystem as a way to extend platform powerIntegration moat and distribution leveragePartner list, API terms, revenue share, partner churn
Hellman & FriedmanMinority strategic investor and board representation in 2021Growth-equity support and governance disciplineBoard rights, exit expectations, control provisions
Dragoneer Investment GroupExisting investor increased investment in 2021Long-duration growth-capital investor signalCurrent ownership and secondary-sale history
Collective Medical acquisition/platformBusinessWire release references Collective Medical acquisitionCross-continuum network/data assetIntegration KPIs, data rights and inherited liabilities
Customer references across care continuumPublic customer stories span risk-bearing providers, hospitals and long-term careExpansion beyond core LTPACIndependent reference calls and churn history

Relationship economics are not public.

Supplier and dependency diligence map
Dependency categoryPublic evidenceRiskRequest
Cloud infrastructureNo named hosting provider located in public sourcesOperational resilience and PHI hosting controls unknownCloud architecture, subprocessors, uptime history, DR/BCP tests
Security/compliance auditorsTrust Center lists SOC/HITRUST certifications but not all report detailsExceptions or scope limitations may matterSOC 1/SOC 2/HITRUST reports, bridge letters
Marketplace/integration partnersMarketplace exists; partner roster economics not publicPartner outages/security events can affect customer valuePartner security review process and revenue share
Data access/interoperability counterpartiesReal Time litigation shows third-party analytics/data-access conflictBlocking or access-control disputes can create legal and customer riskAPI/data-access policies and disputes log
Public-sector/regulatory data sourcesGovernment/HIE and compliance-oriented pages indicate regulated workflows but source dependencies are not disclosedPolicy or data standard changes can raise R&D burdenDependency map for CMS/ONC/state reporting integrations

Named vendors and contracts require company disclosure.

III.C Revenue by customer

not publicly verifiable confidence: medium

Revenue by customer is not public. Customer stories and scale metrics provide presence signals, not concentration analysis.

Evidence gaps

  • Revenue concentration, NRR/churn by cohort, contract renewal calendar and AR aging are missing.

Hidden risks

  • A small number of enterprise chains, payers or health systems could carry outsized ARR or negotiation leverage.

Follow-up questions

  • Provide ARR by customer, parent account, facility count and product module.
  • Provide renewal schedule and churn/downsells for the last twelve quarters.

III.D Significant relationships severed within the last two years

not publicly verifiable confidence: low

No public schedule of lost major customers or severed strategic relationships was available.

Evidence gaps

  • Lost customer/partner schedule, dispute notices and non-renewal reasons are missing.

Hidden risks

  • Recent churn or partner terminations could be hidden by curated customer stories.

Follow-up questions

  • Provide lost customer report and top non-renewal/downsells for the last 24 months.
  • Provide partner termination/dispute log.

III.E Top suppliers

not publicly verifiable confidence: medium

Named top suppliers are not public. Diligence should focus on cloud hosting, security auditors, marketplace partners, data-access counterparties and regulatory data dependencies.

Evidence gaps

  • Subprocessor list, cloud architecture, DR tests, security vendor scope and partner SLAs are missing.

Hidden risks

  • Undisclosed cloud/subprocessor or API dependencies could create outage, security or contractual exposure.

Follow-up questions

  • Provide supplier/subprocessor schedule, top spend suppliers, DR/BCP tests and vendor risk reviews.
Chapter 04

04Competition

PointClickCare appears deeply positioned in long-term/post-acute care, but MatrixCare, Netsmart and WellSky publicly market overlapping suites, while acute/payer expansion increases exposure to broader healthcare platform competitors.

IV.A Competitive landscape by market segment

partially verified confidence: medium

Public competitor pages confirm overlapping market coverage. Competitive underwriting requires independent share data, win/loss analysis and pricing/discounting evidence.

Evidence gaps

  • Win/loss, share by segment, competitive pricing, switching costs and independent customer satisfaction data are missing.

Hidden risks

  • Competitors may compress pricing or win greenfield/replace deals if PointClickCare modules lag.
  • Expansion outside core LTPAC may encounter larger acute/payer data-network incumbents.

Follow-up questions

  • Provide competitive win/loss by quarter and segment.
  • Commission or obtain independent market-share/customer satisfaction research.
Competitive landscape by segment
CompanySegment overlapPublic positioningDiligence implication
PointClickCareSenior living, skilled nursing, LTPAC, hospitals, risk-bearing providersBroad healthcare software platform, marketplace and cross-continuum pagesIncumbent scale and breadth but must defend interoperability/data network
MatrixCareSkilled nursing and post-acute softwareMarkets skilled nursing software solutionsDirect replacement/competitive bid risk
NetsmartLong-term care and provider softwareMarkets myUnity/long-term care solutionsCompetes on integrated provider workflows and enterprise relationships
WellSkyLong-term care, post-acute and care coordinationMarkets long-term care solutionsCompetes across adjacent post-acute workflows
Epic/Oracle/Cerner/Bamboo Health and other acute/network playersHospitals, HIE, data exchange, care coordinationNot deeply profiled in this standard reportNeeded for acute/payer expansion thesis and interoperability risk

Competitor comparison is public-positioning only; win/loss data not available.

Basis of competition and evidence gaps
DimensionPointClickCare public signalCompetitor signalEvidence gap
Installed base / network effectsCompany/press claims 21,000+ to 27,000+ providers and hospital connectivityCompetitors market similar segment solutions but no public share comparisonActive paying logos, retention, conversion by segment
Workflow breadthEHR, billing, care/service delivery, lab/imaging, marketplace, AI supportMatrixCare/Netsmart/WellSky market broad post-acute suitesModule-level win/loss and product quality scores
Interoperability/data accessMarketplace and cross-continuum positioning; Real Time litigation shows access disputeCompeting networks/acute EHR ecosystems may pressure data access economicsAPI policy, information-blocking controls, partner satisfaction
Security/complianceTrust Center lists SOC/HITRUST and PHI/PII contextHealthcare competitors likely carry comparable compliance expectationsAuditor reports, incident history, customer security questionnaires
Pricing and implementationNo public pricing; enterprise demo modelCompetitor pricing not public in reviewed pagesACV, discounting, implementation duration, services margin

No independent market-share survey was obtained.

Competitive market map Market map plotting public-positioning breadth and healthcare-continuum focus for selected competitors.
Chapter 05

05Marketing, Sales, and Distribution

Public website structure implies direct enterprise sales supported by vertical pages, customer stories, trust proof points and marketplace ecosystem, but CAC, payback, quota attainment, pipeline conversion and budget sufficiency are not public.

V.A Strategy and implementation

partially verified confidence: medium

PointClickCare appears to use vertical-solution marketing, request-demo flows, customer proof points, investor-backed growth messaging and marketplace ecosystem positioning.

Evidence gaps

  • GTM plan, channel mix, campaign ROI, CAC and sales-cycle data are missing.

Hidden risks

  • Marketing claims may outpace independently verified outcomes or conversion efficiency.

Follow-up questions

  • Provide marketing plan, budget, CRM funnel, campaign ROI and bookings by channel.
GTM channel and vertical strategy signals
Channel or motionPublic evidenceLikely roleUnknowns
Direct enterprise demoHomepage navigation includes request-demo pathsPrimary sales conversion pathLead volume, MQL-to-SQL conversion, sales cycle
Vertical solution pagesIndustry pages for senior living, skilled nursing, hospitals, ACO/risk-bearing providers and moreSegment-specific demand capture and SEOPipeline by vertical and CAC
Customer-story/reference sellingCustomer-story hub with named examplesProof points for enterprise buying committeesReference conversion rates and customer satisfaction
Marketplace/partner channelMarketplace page positions partner ecosystemExpansion, integrations and partner influencePartner-sourced ARR and partner SLAs
Investor-backed growthH&F/Dragoneer transaction framed next phase of growthCapital and board support for expansionGrowth plan, exit timeline, budget capacity

GTM inference from public website; no internal funnel metrics.

Public marketing proof-point inventory
Proof pointEvidenceStrengthConcern
Healthcare software category leadershipHomepage and release position PointClickCare as leader in cloud healthcare software for long-term/post-acute careMedium - company sourceRequires independent market-share validation
Scale in U.S. skilled nursingBusinessWire claimed about 65% of U.S. SNFs use PointClickCareMedium/high - company releaseDefinition of use vs paid active facility not public
Cross-continuum expansionHospital/health system and ACO/risk-bearing provider pagesMedium - company sourceSegment revenue mix and retention not public
Security postureTrust Center lists certifications and PHI/PII contextMedium - company trust portalUnderlying exceptions and incident history unknown
Customer success storiesNamed customer-story hubMedium - curated sourceSelection bias; not a full customer reference set

Marketing proof points require validation through customer calls and independent market studies.

Public GTM funnel hypothesis Hypothetical public GTM funnel based on website motions; counts intentionally null because conversion data are not public.

Counts are intentionally null to avoid fabricating funnel metrics.

V.B Major Customers

not publicly verifiable confidence: medium

Major-customer evidence is limited to curated customer stories and scale claims; no revenue-ranked customer list is public.

Evidence gaps

  • Top customer list, expansion/churn history and concentration by parent company are missing.

Hidden risks

  • Largest customers may have custom pricing, termination rights or unresolved disputes.

Follow-up questions

  • Provide top 25 customer list by ARR and renewal date with reference-call candidates.

V.C Principal avenues for generating new business

partially verified confidence: medium

Public evidence points to direct demo, vertical pages, customer stories and marketplace/partner influence as new-business avenues.

Evidence gaps

  • Pipeline source mix, partner-sourced ARR and sales-cycle duration by segment are missing.

Hidden risks

  • Partner-sourced leads and cross-continuum expansion may require different sales capacity than core SNF/senior living.

Follow-up questions

  • Provide pipeline source analysis and conversion metrics by vertical/channel for last eight quarters.

V.D Sales force productivity model

not publicly verifiable confidence: low

No sales productivity model is public. The report cannot estimate CAC payback, rep ramp or quota attainment from available sources.

Evidence gaps

  • Sales headcount, quota capacity, productivity, bookings, pipeline conversion and discounting are missing.

Hidden risks

  • A large sales/support organization may hide declining productivity or rising CAC.

Follow-up questions

  • Provide CRM export, sales capacity model, quota attainment, rep ramp and CAC/payback analysis.

V.E Ability to implement marketing plan with current and projected budgets

not publicly verifiable confidence: low

Budget sufficiency cannot be assessed without S&M spend, pipeline plan, segment expansion targets and ROI metrics.

Evidence gaps

  • Marketing budget, headcount plan, campaign ROI and segment-level bookings targets are missing.

Hidden risks

  • Budget may be insufficient for hospital/payer expansion or too high if core market saturates.

Follow-up questions

  • Provide current-year and next-year S&M budget, hiring plan and pipeline-coverage analysis.
Chapter 06

06Research and Development

Public product pages show active product breadth and AI/interoperability themes, but R&D organization, architecture, roadmap, AI governance, uptime and acquisition integration are not public.

VI.A Description of R&D organization

not publicly verifiable confidence: medium

No complete R&D org chart was public. Product/trust pages imply significant engineering/security capabilities, and the Collective Medical acquisition adds integration scope.

Evidence gaps

  • Engineering headcount, architecture diagrams, uptime/SLA history, SDLC, incident logs and acquisition integration plans are missing.

Hidden risks

  • R&D capacity, security exceptions or acquired-platform tech debt may constrain roadmap delivery.

Follow-up questions

  • Provide R&D org chart, roadmap, architecture, uptime, SDLC controls, security exceptions and tech-debt register.
R&D organization and technical controls gap map
AreaPublic evidenceStatusFollow up
Engineering organizationNo detailed engineering org chart foundNot publicly verifiableEngineering headcount by function/location; attrition; leadership bios
Security development lifecycleTrust Center references security program and certificationsPartially verifiedSDLC policy, SAST/DAST, pentest summaries, exception list
Architecture and uptimeNo architecture or SLA history publicNot publicly verifiableArchitecture diagrams, uptime/SLA reports, DR tests
AI/model governanceAI-powered Resident Status marketed; no validation publicPartially verified product label; controls missingModel cards, validation sets, drift monitoring, human override workflow
Interoperability/APIMarketplace and litigation indicate importance of data accessPartially verifiedAPI docs, data-sharing policies, partner dispute log

R&D org is a major data-room request.

R&D and product-risk architecture Conceptual R&D risk map linking product themes, data dependencies and controls.

VI.B New Product Pipeline

partially verified confidence: medium

Public pipeline themes include AI-powered nursing support, senior-living EHR enhancements, marketplace/interoperability and cross-continuum workflows; committed roadmap and validation data are not public.

Evidence gaps

  • Roadmap dates, R&D spend, model validation, API strategy and customer pilot results are missing.

Hidden risks

  • Product roadmap may depend on unresolved data-access/legal policy choices.

Follow-up questions

  • Provide roadmap with committed/released dates, model validation reports and API/interoperability compliance plan.
Product roadmap and pipeline evidence table
ThemePublic signalValidation neededRisk link
AI-powered resident status / nursing supportNursing Support Package page references AI-powered Resident StatusClinical validation, model governance, adoption, incident loggingProduct efficacy and regulatory/reputational risk
Senior Living EHR modernizationSenior Living EHR page lists engagement, wellness, dashboards and collaborationRelease roadmap, migration plan, module attach ratesExecution and adoption risk
Cross-continuum / Collective Medical integrationBusinessWire release mentions Collective Medical acquisition and broader growthIntegration roadmap, data rights, cross-sell resultsIntegration and inherited-liability risk
Marketplace ecosystem expansionMarketplace page highlights partner ecosystemPartner onboarding roadmap, API strategy, security reviewsPartner/API risk
Regulatory interoperability/data accessReal Time litigation spotlights access-control disputesInformation-blocking compliance roadmap and API strategyLegal/regulatory risk

Public pages identify themes, not committed release dates or R&D budget.

Chapter 07

07Management and Personnel

Public evidence confirms founder-control signals and a large employee base, but current organization chart, senior-team biographies, compensation, incentive stock plans, employee relations and turnover are not public.

VII.A Organization Chart

partially verified confidence: medium

Only limited governance/role signals are public: founders/control, H&F board participation and CISO/security leadership; a current org chart is not public.

Evidence gaps

  • Current org chart, board composition, management-team bios and succession plan are missing.

Hidden risks

  • Founder control and limited public succession data create key-person diligence risk.

Follow-up questions

  • Provide current board/management org chart, executive bios and succession materials.
Management, board and governance signals
Role or groupPublic signalVerificationDiligence need
Mike WessingerNamed founder/control/operator in historical filing and 2021 release contextVerified historical/public transaction signalCurrent role, equity/voting control, employment agreement
David WessingerNamed founder/control/operator in historical filing and 2021 release contextVerified historical/public transaction signalCurrent role, equity/voting control, employment agreement
Hellman & Friedman board/investor seatBusinessWire release stated H&F would hold a board seatVerified transaction claimBoard composition, consent rights, investor conflicts
Security leadership/CISO functionTrust Center references Information Security Team led by CISOPartially verified via trust portalCISO tenure, team size, incidents, risk committee reporting
Broader senior management teamNo complete current org or bios validated in this reviewNot publicly verifiableFull executive bios, departures, succession and references

Leadership information is partial and should not be treated as a current org chart.

Public governance / leadership evidence map Evidence-limited org chart showing only public-control and security-leadership signals.

Not a verified current org chart; only public signals are displayed.

VII.B Historical and projected headcount by function and location

partially verified confidence: medium

Communitech reported about 2,100 employees and 500 hires that year, but function/location mix and projections are not public.

Evidence gaps

  • Historical and projected headcount by function/location, attrition and hiring plan are missing.

Hidden risks

  • Rapid hiring can strain culture, support quality and productivity.

Follow-up questions

  • Provide monthly headcount by function/location for 36 months and hiring plan by role.
Headcount and hiring signals
MetricReported valueSourceInterpretation
Total employeesAbout 2,100 employeesCommunitechLarge mature SaaS workforce; current number must be verified
Hiring plan/activityAbout 500 hires in the year referenced by CommunitechCommunitechGrowth-mode hiring; need attrition and productivity analysis
Function/location mixNot publicNo public source locatedCannot assess R&D vs sales vs support leverage
TurnoverNot publicNo public source locatedMust request voluntary/involuntary turnover and key departures
Compensation/stock plansNot publicNo public source locatedImportant because of private-company liquidity and prior secondary sale

Public headcount estimates do not reveal productivity or culture.

Headcount public-signal chart Chart of available public workforce scale metrics.

Only two public workforce data points were found; do not infer a trend.

VII.C Senior management biographies

partially verified confidence: medium

Founder names and historical company context are public; full current senior management biographies were not validated in this review.

Evidence gaps

  • Current executive bios, references, prior roles and recent departures are missing.

Hidden risks

  • Management bench depth and experience may be weaker than scale implies.

Follow-up questions

  • Provide management biographies, references and key-departure history.

VII.D Compensation arrangements

not publicly verifiable confidence: low

No current executive or employee compensation arrangements are public.

Evidence gaps

  • Executive compensation, bonus plans, severance, change-in-control and retention arrangements are missing.

Hidden risks

  • Compensation terms may create retention risk or deal cost.

Follow-up questions

  • Provide executive compensation schedule and employment/retention agreements.
Compensation, employee relations and retention gap table
TopicPublic statusRiskRequest
Executive compensationNot publicMisaligned incentives or key-person retention riskCompensation schedule, change-in-control terms, bonus plans
Option/incentive plansNo current plan docs public; historical/secondary liquidity referenced in pressDilution and retention impactEquity plan, option pool, tender/secondary documents
Employee relations problemsNo comprehensive public search outcomeCulture/productivity/legal exposure could be hiddenHR claims log, severance disputes, engagement survey
Turnover by functionNot publicHigh support/engineering turnover could impair healthcare SaaS reliability24-month attrition by function/level/location
Key-person successionFounder control publicly indicated, succession not publicControl concentration and management transition riskSuccession plan and delegation/board oversight materials

People diligence is under-evidenced from public sources.

VII.E Incentive stock plans

not publicly verifiable confidence: medium

Current incentive stock plans, option pool and employee liquidity details are not public; press reported employee participation in secondary sale.

Evidence gaps

  • Equity plan, option pool, tender history and unvested/vested option schedules are missing.

Hidden risks

  • Prior liquidity can affect retention, refresh grants and option-pool dilution.

Follow-up questions

  • Provide equity incentive plan, option pool, grant history and tender documents.

VII.F Significant employee relations problems, past or present

inconclusive confidence: low

No comprehensive public evidence of employee-relations problems was validated, but no certified negative search was performed.

Evidence gaps

  • HR claims logs, labor disputes, litigation and engagement survey history are missing.

Hidden risks

  • Employee relations disputes could be hidden from public sources and affect retention/reputation.

Follow-up questions

  • Provide HR claims schedule, employee-relations matters and engagement/exit survey summaries.

VII.G Personnel Turnover

not publicly verifiable confidence: low

Personnel turnover is not public. Large workforce and growth hiring make attrition/productivity diligence important.

Evidence gaps

  • Voluntary/involuntary turnover by function, regretted attrition, open roles and time-to-fill are missing.

Hidden risks

  • High attrition in engineering, implementation or support could impair delivery and customer success.

Follow-up questions

  • Provide monthly turnover by function/location/level and key departure explanations for 24 months.
Chapter 08

08Legal and Related Matters

The highest-priority public legal issues are PHI/privacy/security obligations and the Real Time interoperability/data-access litigation. IP, insurance, material contracts, BAAs/DPAs and regulatory/enforcement searches remain under-verified.

VIII.A Pending lawsuits against the Company

partially verified confidence: high

The Real Time appellate opinion is the most material public litigation evidence found; broader docket search requires counsel triage.

Evidence gaps

  • Current docket status, reserves, legal fees, settlement posture and customer communications are missing.

Hidden risks

  • Litigation could affect API policy, customer obligations, product design and partner strategy.

Follow-up questions

  • Counsel to provide complete litigation schedule and status memo for Real Time and other matters.
Litigation against or affecting the company
MatterStatus or stageAllegations or issueDiligence implication
Real Time Medical Systems, Inc. v. PointClickCare Technologies, Inc.Fourth Circuit affirmed preliminary injunction in 2025Third-party analytics vendor access to PointClickCare EHR data; bot/CAPTCHA blocking; unfair competition/information-blocking contextHigh-priority counsel review for API policy, customer obligations and regulatory exposure
CourtListener broader referencesAggregated search returned multiple referencesNot triaged in this standard reviewCounsel should classify all open/closed matters by materiality
HHS OCR/FTC enforcementNo specific enforcement validatedOfficial searches not exhaustively exportedObtain counsel-certified negative searches and breach history

Not a legal opinion; counsel must verify current docket statuses.

Legal and regulatory event timeline Timeline of major public legal/regulatory events identified.

VIII.B Pending lawsuits initiated by Company

inconclusive confidence: low

No complete schedule of affirmative claims was public. Real Time may include claims/defenses, and CourtListener search should be triaged.

Evidence gaps

  • All threatened/pending/settled claims initiated by the company are missing.

Hidden risks

  • Undisclosed disputes can create legal costs or strategic constraints.

Follow-up questions

  • Provide legal schedule of all affirmative claims, counterclaims, demand letters and settlements.
Lawsuits initiated by the company / claims posture
CategoryPublic evidenceStatusRequest
Affirmative claims in Real Time matterOpinion describes litigation posture including PointClickCare defenses/claims related to bot access and system integrityPartially verified from appellate opinionFull pleadings, counterclaims, settlement discussions, fees/reserves
Other affirmative litigationCourtListener search requires matter-by-matter triageUnverifiedLegal schedule of all threatened, pending and settled claims
IP enforcementNo public patent/trademark enforcement record validated in this reviewInconclusiveIP counsel schedule and cease-and-desist history

Legal docket search was issue-discovery, not exhaustive litigation diligence.

VIII.C Environmental and employee safety issues and liabilities

inconclusive confidence: low

As a software company, environmental exposure appears lower, but office leases, workplace safety, remote-work and employment claims were not publicly reviewed in detail.

Evidence gaps

  • Environmental/office lease obligations, OSHA/workplace claims and employment-law schedule are missing.

Hidden risks

  • Office/employee safety or employment claims can still create liabilities even for SaaS businesses.

Follow-up questions

  • Provide facilities/lease schedule, environmental questionnaires and workplace safety/employee claims log.
Legal, IP, privacy, insurance and contracts diligence matrix
AreaPublic evidenceRisk levelNeeded documents
Privacy/security/HIPAA/PHITrust Center and Privacy Policy identify PHI/PII, SOC/HITRUST and privacy categoriesHighBAAs, DPAs, SOC reports, incident log, OCR/breach searches, cyber-insurance policies
Information blocking/interoperabilityReal Time appellate opinion and data-access disputeHighAPI policies, ONC/Cures Act analyses, customer notices, litigation reserves
Patents/trademarks/IP ownershipSearch destinations identified; chain-of-title unverifiedMediumPatent/trademark schedules, assignments, OSS scan, acquisition IP assignments
Material contractsContracts not public; trust/privacy imply regulated customer agreementsHighCustomer MSAs, BAAs, SLAs, public-sector contracts, partner agreements
InsuranceNo policy schedules publicMedium/highCyber, E&O, D&O, professional liability, claims history
Environmental/employee safetyNo material environmental operations identified from public SaaS profileLow/unknownOffice leases, workplace safety claims, ESG/environmental questionnaires

Legal matrix prioritizes PHI/security and information-blocking over ordinary SaaS legal items.

VIII.D Material patents, copyrights, licenses, and trademarks

inconclusive confidence: low

Formal IP diligence is incomplete. Search destinations were identified, but patent/trademark record exports, assignments, OSS scans and acquisition IP transfers are not verified.

Evidence gaps

  • IP schedule, patent/trademark docket export, assignments, OSS/SBOM and acquisition IP reps are missing.

Hidden risks

  • Missing assignments or OSS/license issues could impair defensibility or create indemnity exposure.

Follow-up questions

  • IP counsel to provide trademark/patent/OSS schedule and chain-of-title memo.
Top-risk heatmap Heatmap of major diligence risks by severity and likelihood.

VIII.E Insurance coverage and material exposures

not publicly verifiable confidence: medium

Insurance coverage is not public. Cyber, E&O/professional liability, D&O and health-data exposures should be reviewed against PHI and litigation risks.

Evidence gaps

  • Insurance policies, claims history, retention levels and broker summaries are missing.

Hidden risks

  • Insurance exclusions or inadequate limits could leave material uncovered losses.

Follow-up questions

  • Provide cyber, E&O, D&O, GL and umbrella policies plus claims history.

VIII.F Material contracts

not publicly verifiable confidence: medium

Material customer, partner, BAA/DPA, SLA, public-sector and acquisition contracts are not public.

Evidence gaps

  • Top customer MSAs, BAAs, DPAs, partner agreements, acquisition agreements and public-sector terms are missing.

Hidden risks

  • BAA, SLA, indemnity, data-use and termination terms may materially alter risk and valuation.

Follow-up questions

  • Provide material-contract schedule and samples for top customers, partners and acquired assets.

VIII.G Regulatory agency problems

partially verified confidence: medium

No specific FTC/HHS OCR enforcement action was validated, but formal negative searches were not completed. PHI/privacy, SOC/HITRUST scope and information-blocking compliance are high-priority diligence areas.

Evidence gaps

  • Formal regulatory search reports, correspondence, breach logs and compliance committee materials are missing.

Hidden risks

  • Healthcare regulatory changes or adverse agency findings could require product changes or customer remediation.

Follow-up questions

  • Healthcare regulatory counsel to review HIPAA/PHIPA/ONC/Cures Act compliance, agency correspondence and breach history.

Evidence

Evidence claims
IDClaimStatusSources
EC-001 User-provided unicorn-list metadata identifies PointClickCare as a private unicorn at about US$4B. partially verified medium SRC-001
EC-002 CB Insights lists PointClickCare valuation at US$4.0B in January 2021 and total disclosed funding of US$86.91M over six rounds. partially verified medium SRC-002
EC-003 PointClickCare announced a 2021 minority strategic investment by Hellman & Friedman and Dragoneer, with founders continuing to control and operate the company. verified high SRC-003
EC-004 Independent press reported the 2021 transaction valued PointClickCare at approximately US$4B and involved secondary sales by JMI, employees and other holders. partially verified medium SRC-004SRC-005
EC-005 Communitech later reported PointClickCare valuation above US$5B, revenue above US$500M, roughly 20% growth, about 2,100 employees, 27,000+ long-term-care providers, and 2,700 hospitals. partially verified medium SRC-006
EC-006 PointClickCare filed an F-1/F-1A in 2015-2016 and withdrew the registration in 2017; no securities were issued or sold under that registration. verified high SRC-007SRC-008SRC-009SRC-029
EC-007 The 2016 F-1/A described PointClickCare as a leading cloud-software provider for North American senior care with 2015 revenue of US$125.4M and about 2,400 providers across 12,200 facilities. verified high SRC-008
EC-008 PointClickCare remains an active healthcare software vendor with product pages for senior living, skilled nursing, providers, health plans, hospitals, HIE/government, life sciences, pharmacy and other segments. verified high SRC-010SRC-011SRC-012SRC-013
EC-009 PointClickCare product pages describe Senior Living EHR, billing, care/service delivery, lab and imaging integration, nursing support, and related packages. verified medium SRC-011SRC-014SRC-019
EC-010 PointClickCare publicly highlights named customer stories including Tandigm Health, Transitional Care Physicians, Torrance Memorial/MLK, Westmoreland Manor and Ascension-related content. partially verified medium SRC-015
EC-011 PointClickCare markets a partner marketplace intended to extend the platform through ecosystem integrations. verified medium SRC-016
EC-012 PointClickCare markets solutions beyond long-term/post-acute care into hospitals/health systems and risk-bearing providers. verified medium SRC-017SRC-018
EC-013 PointClickCare Trust Center states that Senior Care EHR has PHI/PII access and SOC 2 Type 2/SOC 1 Type 2 certifications, while the Collective Platform has HITRUST certification. partially verified medium SRC-020
EC-014 PointClickCare Privacy Policy states it covers platform services and site use and defines PI/PII/SPI/PHI/personal health information categories. verified high SRC-021
EC-015 In Real Time Medical Systems v. PointClickCare, the Fourth Circuit affirmed a preliminary injunction against PointClickCare related to blocking bot-enabled access to EHR records by a third-party analytics vendor. verified high SRC-022
EC-016 CourtListener search produced multiple PointClickCare-related legal references, but materiality beyond Real Time requires counsel triage. partially verified low SRC-023
EC-017 Patent and trademark ownership for PointClickCare requires formal IP search/export; public search URLs alone were insufficient for chain-of-title verification. inconclusive low SRC-024SRC-025
EC-018 MatrixCare, Netsmart and WellSky publicly market long-term/post-acute care software solutions that overlap PointClickCare target segments. verified high SRC-026SRC-027SRC-028
EC-019 No public evidence of current IPO completion, acquisition or shutdown was found; available evidence supports continuing as a private operating company. partially verified medium SRC-003SRC-006SRC-007SRC-009SRC-010
EC-020 Company scale is substantial, but current audited financials, ARR, gross margin, net retention, cash balance and debt are not public. not publicly verifiable medium SRC-006SRC-008
EC-021 Public sources do not disclose SKU pricing, ACV by product, implementation fees or gross margin by module. not publicly verifiable medium SRC-011SRC-014SRC-019
EC-022 Top customers, revenue concentration, churn and NPS/CSAT are not publicly disclosed. not publicly verifiable medium SRC-015SRC-003SRC-006
EC-023 Public pages suggest a direct enterprise GTM supported by vertical solutions, demos, customer stories and marketplace ecosystem, but CAC, sales productivity and pipeline conversion are not public. partially verified medium SRC-010SRC-012SRC-015SRC-016SRC-017SRC-018
EC-024 Current R&D organization, technical architecture, AI governance, uptime and product roadmap are not publicly verifiable at standard depth. not publicly verifiable medium SRC-011SRC-019SRC-020
EC-025 Communitech reported approximately 2,100 employees and roughly 500 hires in the relevant year, but current org structure, turnover and compensation are not public. partially verified medium SRC-006
EC-026 Mike and Dave Wessinger are the founding figures identified in historical filings, and public sources indicate founder control persisted after the 2021 transaction. verified high SRC-003SRC-008
EC-027 Material contracts, insurance coverage, indemnities, BAAs, DPAs and public-sector contract obligations are not public. not publicly verifiable medium SRC-020SRC-021
EC-028 Handling PHI/PII in senior-care and acute/post-acute workflows creates high privacy, cybersecurity and regulatory exposure. verified high SRC-020SRC-021SRC-022
EC-029 PointClickCare acquired Collective Medical before the 2021 H&F transaction, supporting cross-continuum expansion but adding integration risk. verified medium SRC-003
EC-030 No specific FTC or HHS OCR enforcement action against PointClickCare was validated in this review, but official searches were not exhaustively exported. inconclusive low SRC-030SRC-031
Sources
IDPublisherTitleAccessed
SRC-001 User-provided / CB Insights-derived list User-provided CB Insights unicorn list metadata for PointClickCare 2026-05-21
SRC-002 CB Insights PointClickCare financials profile 2026-05-21
SRC-003 BusinessWire / PointClickCare PointClickCare Technologies Enters Next Phase of Growth with Minority Strategic Investment from New Investor Hellman & Friedman and Existing Investor Dragoneer Investment Group 2026-05-21
SRC-004 BetaKit PointClickCare reportedly valued at $4 billion USD following new minority investment 2026-05-21
SRC-005 The Globe and Mail PointClickCare financing values Canadian software provider at US$4-billion as backer JMI mostly cashes out 2026-05-21
SRC-006 Communitech PointClickCare's value rises to US$5B 2026-05-21
SRC-007 U.S. Securities and Exchange Commission SEC EDGAR company search: PointClickCare Corp., CIK 0001606766 2026-05-21
SRC-008 U.S. Securities and Exchange Commission PointClickCare Corp. Form F-1/A registration statement 2026-05-21
SRC-009 U.S. Securities and Exchange Commission PointClickCare Corp. Form RW withdrawal request 2026-05-21
SRC-010 PointClickCare PointClickCare homepage: Healthcare Software for Smarter Care Delivery 2026-05-21
SRC-011 PointClickCare Healthcare Software Products for Providers 2026-05-21
SRC-012 PointClickCare Senior Living Software Solutions 2026-05-21
SRC-013 PointClickCare Skilled Nursing Software Solutions 2026-05-21
SRC-014 PointClickCare Senior Living EHR product page 2026-05-21
SRC-015 PointClickCare Customer Stories 2026-05-21
SRC-016 PointClickCare Marketplace 2026-05-21
SRC-017 PointClickCare Hospitals and Health Systems industry page 2026-05-21
SRC-018 PointClickCare Accountable Care Organizations & Risk-Bearing Providers industry page 2026-05-21
SRC-019 PointClickCare Nursing Support Package product page 2026-05-21
SRC-020 PointClickCare PointClickCare Trust Center 2026-05-21
SRC-021 PointClickCare PointClickCare Privacy Policy 2026-05-21
SRC-022 U.S. Court of Appeals for the Fourth Circuit Real Time Medical Systems, Inc. v. PointClickCare Technologies, Inc., No. 24-1773 2026-05-21
SRC-023 CourtListener / Free Law Project CourtListener search results for PointClickCare 2026-05-21
SRC-024 Google Patents Google Patents assignee search for PointClickCare Technologies Inc. 2026-05-21
SRC-025 U.S. Patent and Trademark Office USPTO Trademark Search for PointClickCare 2026-05-21
SRC-026 MatrixCare MatrixCare skilled nursing software 2026-05-21
SRC-027 Netsmart Netsmart myUnity long-term care software 2026-05-21
SRC-028 WellSky WellSky long-term care software 2026-05-21
SRC-029 U.S. Securities and Exchange Commission SEC submissions JSON: PointClickCare Corp. 2026-05-21
SRC-030 U.S. Department of Health and Human Services HHS OCR Breach Portal search destination 2026-05-21
SRC-031 U.S. Federal Trade Commission FTC enforcement search destination 2026-05-21

Disclaimer

This report is a public-evidence diligence snapshot, not investment advice. Important financial, legal, technical, and contractual facts remain non-public and should be verified directly with management and primary documents before any investment decision.